Levels Health funding, valuation and investors

Overview

Levels Health is a metabolic health company offering a membership program built around continuous glucose monitors (CGMs). Members wear CGMs and use the Levels app to see how meals, sleep, stress, and exercise affect blood sugar, with optional coaching and content. Founded by Sam Corcos and team, Levels raised a $12M seed in November 2020 led by Andreessen Horowitz, followed by approximately $38M Series A in 2022 with a16z participation and a broad operator/angel syndicate.

Why Levels Health is interesting

Levels turned continuous glucose monitors into a DTC wellness category before Apple Watch got serious about metabolic health — a16z led its $12M seed and re-upped in Series A as members paid for real-time feedback on food, sleep, and exercise.

Product & use cases

Levels provides CGM hardware (via pharmacy partners), a mobile app scoring meals and activities by glucose response, educational content on metabolic health, and optional coaching. It targets health-conscious consumers and biohackers, not diabetic clinical treatment.

• Optimizing diet by seeing real-time glucose spikes from specific foods
• Correlating sleep quality and exercise with next-day metabolic response
• Preventive wellness for nondiabetic adults curious about metabolic fitness

Key facts

• Seed (Nov 2020): $12M led by a16z (Levels blog)
• Series A (~2022): ~$38M with a16z participation (Fierce Healthcare)
• Membership model around CGM data for nondiabetic metabolic optimization
• Founded by Sam Corcos; team includes prominent health/tech operators

Funding history (newest first)

Investors in our directory

Funds linked from Levels Health's profile — open a fund page for stage focus and related deal articles.

Competitive landscape

Edge: Levels built brand and content early in the CGM wellness wave — combining hardware access, software UX, and a membership community before big tech integrated glucose sensing. a16z's seed lead signaled consumer health infra, not just another fitness app.

CGM wellness sits between medical devices and lifestyle apps. Levels competes on community and content while CGM supply and FDA boundaries constrain scale. Long-term risk is platform commoditization if Apple or Samsung ship glucose features to hundreds of millions of watches.

• Nutrisense direct

  Competing CGM coaching membership with dietitian support; similar DTC metabolic health positioning.

• Signos direct

  CGM-based weight and metabolic health program; overlaps on consumer glucose monitoring.

• Apple Watch / wearable glucose (future) incumbent

  Platform risk if non-invasive glucose monitoring ships on mass-market wearables.

Notable stories

• Levels launched during the peak biohacking interest in CGMs for nondiabetics — a controversial but fast-growing niche that a16z backed as preventive health infrastructure.
• Founder Sam Corcos built Levels with heavy transparency on company operations, becoming a reference point for remote-first startup culture in health tech.

Industries